Abstract
Meniere’s disease (MD) consists of a tetrad of episodic vertigo, fluctuating sensorineural hearing loss, tinnitus, and aural fullness. The episodic vertigo typically resolves over time; however, hearing loss usually becomes permanent with disease progression. MD is thought to be caused by endolymphatic hydrops, which has been visualized both in pathologic temporal bone specimens and in vivo via magnetic resonance imaging. Multiple theories exist regarding the etiology of endolymphatic hydrops and the mechanism by which endolymphatic hydrops causes the symptoms of MD. MD is principally diagnosed based on clinical assessment and audiometric documentation of hearing loss; however, a variety of adjunct vestibular tests can be used to differentiate MD from similar disorders.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Sajjadi H, Paparella MM. Meniere’s disease. Lancet. 2008;372(9636):406–14.
Tyrrell JS, Whinney DJ, Ukoumunne OC, Fleming LE, Osborne NJ. Prevalence, associated factors, and comorbid conditions for Meniere’s disease. Ear Hear. 2014;35(4):e162–9.
Goebel JA. 2015 equilibrium committee amendment to the 1995 AAO-HNS guidelines for the definition of Ménière’s disease. Otolaryngol Head Neck Surg. 2016;154:403–4.
Mancini F, Catalani M, Carru M, Monti B. History of Meniere’s disease and its clinical presentation. Otolaryngol Clin N Am. 2002;35:565–80.
Paparella MM. Pathogenesis of Meniere’s disease and Meniere’s syndrome. Acta Otolaryngol Suppl. 1984;406:10–25.
Balkany TJ, Sires B, Arenberg IK. Bilateral aspects of Meniere’s disease: an underestimated clinical entity. Otolaryngol Clin N Am. 1980;13:603–9.
Havia M, Kentala E. Progression of symptoms of dizziness in Ménière’s disease. Arch Otolaryngol Head Neck Surg. 2004;130:431.
Mizukoshi K, Shojaku H, Aso S, Watanabe Y. Clinical study of elderly patients with Meniere’s and related diseases. Auris Nasus Larynx. 2000;27:167–73.
Enander A, Stahle J. Hearing loss and caloric response in Menière’s disease. A comparative study. Acta Otolaryngol (Stockh). 1969;67:57–68.
Stahle J, Friberg U, Svedberg A. Long-term progression of Menière’s disease. Am J Otol. 1989;10:170–3.
Sumi T, Watanabe I, Tsunoda A, Nishio A, Komatsuzaki A, Kitamura K. Longitudinal study of 29 patients with Meniere’s disease with follow-up of 10 years or more (in commemoration of professor emeritus Isamu Watanabe). Acta Otolaryngol (Stockh). 2012;132:10–5.
Green JD Jr, Blum DJ, Harner SG. Longitudinal followup of patients with Meniere’s disease. Otolaryngol Head Neck Surg. 1991;104(6):783–8.
Ueberfuhr MA, Wiegrebe L, Krause E, Gürkov R, Drexl M. Tinnitus in normal-hearing participants after exposure to intense low-frequency sound and in Ménière’s disease patients. Front Neurol. 2017;7:239.
Levo H, Kentala E, Rasku J, PyykkF I. Aural fullness in Ménière’s disease. Audiol Neurotol. 2014;19:395–9.
Albers GD, Wilson WH. Diplacusis: II. Etiology. Arch Otolaryngol Head Neck Surg. 1968;87:604–6.
Colin D, Micheyl C, Girod A, Truy E, Gallégo S. Binaural diplacusis and its relationship with hearing-threshold asymmetry. PLoS One. 2016;11:e0159975.
Walsh TE. The diagnosis and treatment of Meniere’s disease. Arch Otolaryngol Head Neck Surg. 1956;64:118–28.
Baloh RW, Jacobson K, Winder T. Drop attacks with Menière’s syndrome. Ann Neurol. 1990;28:384–7.
Black FO, Effron MZ, Burns DS. Diagnosis and management of drop attacks of vestibular origin: Tumarkin’s otolithic crisis. Otolaryngol Head Neck Surg. 1982;90:256–62.
Ozeki H, Iwasaki S, Murofushi T. Vestibular drop attack secondary to Meniere’s disease results from unstable otolithic function. Acta Otolaryngol. 2008;128:887–91.
Kentala E, Havia M, Pyykkö I. Short-lasting drop attacks in Meniere’s disease. Otolaryngol Head Neck Surg. 2001;124:526–30.
Janzen VD, Russell RD. Conservative management of Tumarkin’s otolithic crisis. J Otolaryngol. 1988;17:359–61.
Kimura H, Aso S, Watanabe Y. Prediction of progression from atypical to definite Ménière’s disease using electrocochleography and glycerol and furosemide tests. Acta Otolaryngol (Stockh). 2003;123:388–95.
Kato M, Sugiura M, Shimono M, Yoshida T, Otake H, Kato K, et al. Endolymphatic hydrops revealed by magnetic resonance imaging in patients with atypical Meniere’s disease. Acta Otolaryngol. 2013;133:123–9.
Gurkov R, Pyyko I, Zou J, Kentala E. What is Meniere’s disease? A contemporary re-evaluation of endolymphatic hydrops. J Neurol. 2016;263(Suppl 1):S71–81.
Hallpike CS, Cairns H. Observations on the pathology of Ménière’s syndrome: (section of otology). Proc R Soc Med. 1938;31(11):1317–36.
Paparella MM, Morizono T, Matsunaga T. Kyoshiro Yamakawa, MD, and temporal bone histopathology of Meniere’s patient reported in 1938. Commemoration of the centennial of his birth. Arch Otolaryngol Head Neck Surg. 1992;118(6):660–2.
Hebbar GK, Rask-Andersen H, Linthicum FH Jr. Three-dimensional analysis of 61 human endolymphatic ducts and sacs in ears with and without Meniere’s disease. Ann Otol Rhinol Laryngol. 1991;100(3):219–25.
Shambaugh GE Jr, Clemis JD, Arenberg IK. Endolymphatic duct and sac in Meniere’s disease. Arch Otolaryngol. 1969;89(6):816–25.
Park JJ, Shen A, Keil S, Kuhl C, Westhofen M. Jugular bulb abnormalities in patients with Meniere’s disease using high-resolution computed tomography. Eur Arch Otorhinolaryngol. 2015;272(8):1879–84.
Sando I, Ikeda M. Pneumatization and thickness of the petrous bone in patients with Meniere’s disease. A histopathological study. Ann Otol Rhinol Laryngol Suppl. 1985;118:2–5.
Paparella MM, Djalilian HR. Etiology, pathophysiology of symptoms, and pathogenesis of Meniere’s disease. Otolaryngol Clin N Am. 2002;35(3):529–45. vi
Monsanto RD, Pauna HF, Kwon G, Schachern PA, Tsuprun V, Paparella MM, et al. A three-dimensional analysis of the endolymph drainage system in Meniere disease. Laryngoscope. 2017;127(5):E170–E5.
Lawrence M, McCabe BF. Inner-ear mechanics and deafness. Special consideration of Meniere’s syndrome. J Am Med Assoc. 1959;171:1927–32.
Vasama JP, Linthicum FH Jr. Meniere’s disease and endolymphatic hydrops without Meniere’s symptoms: temporal bone histopathology. Acta Otolaryngol. 1999;119(3):297–301.
Kariya S, Cureoglu S, Fukushima H, Nomiya S, Nomiya R, Schachern PA, et al. Vascular findings in the stria vascularis of patients with unilateral or bilateral Meniere’s disease: a histopathologic temporal bone study. Otol Neurotol. 2009;30(7):1006–12.
Okuno T, Sando I. Localization, frequency, and severity of endolymphatic hydrops and the pathology of the labyrinthine membrane in Meniere’s disease. Ann Otol Rhinol Laryngol. 1987;96(4):438–45.
Nadol JB Jr, Thornton AR. Ultrastructural findings in a case of Meniere’s disease. Ann Otol Rhinol Laryngol. 1987;96(4):449–54.
Nakashima T, Naganawa S, Sugiura M, Teranishi M, Sone M, Hayashi H, et al. Visualization of endolymphatic hydrops in patients with Meniere’s disease. Laryngoscope. 2007;117(3):415–20.
Nakashima T, Naganawa S, Teranishi M, Tagaya M, Nakata S, Sone M, et al. Endolymphatic hydrops revealed by intravenous gadolinium injection in patients with Meniere’s disease. Acta Otolaryngol. 2010;130(3):338–43.
Gurkov R, Flatz W, Louza J, Strupp M, Krause E. In vivo visualization of endolyphatic hydrops in patients with Meniere’s disease: correlation with audiovestibular function. Eur Arch Otorhinolaryngol. 2011;268(12):1743–8.
Tagaya M, Yamazaki M, Teranishi M, Naganawa S, Yoshida T, Otake H, et al. Endolymphatic hydrops and blood-labyrinth barrier in Meniere’s disease. Acta Otolaryngol. 2011;131(5):474–9.
Merchant SN, Adams JC, Nadol JB Jr. Pathophysiology of Meniere’s syndrome: are symptoms caused by endolymphatic hydrops? Otol Neurotol. 2005;26(1):74–81.
Rauch SD, Merchant SN, Thedinger BA. Meniere’s syndrome and endolymphatic hydrops. Double-blind temporal bone study. Ann Otol Rhinol Laryngol. 1989;98(11):873–83.
Pyykko I, Zou J, Poe D, Nakashima T, Naganawa S. Magnetic resonance imaging of the inner ear in Meniere’s disease. Otolaryngol Clin N Am. 2010;43(5):1059–80.
Kimura R, Schuknecht H. Membranous hydrops in the inner ear of the guinea pig after obliteration of the endolymphatic sac. Pract Otorhinolaryngol. 1965;27(6):343–54.
Dunnebier EA, Segenhout JM, Wit HP, Albers FW. Two-phase endolymphatic hydrops: a new dynamic guinea pig model. Acta Otolaryngol. 1997;117(1):13–9.
Watanabe K, Tomiyama S, Jinnouchi K, Yagi T. Apoptosis in the hydropic cochlea of guinea pigs following immune reaction of the endolymphatic sac: immunohistochemical analysis. Eur Arch Otorhinolaryngol. 2001;258(6):296–9.
Marshall AF, Jewells VL, Kranz P, Lee YZ, Lin W, Zdanski CJ. Magnetic resonance imaging of guinea pig cochlea after vasopressin-induced or surgically induced endolymphatic hydrops. Otolaryngol Head Neck Surg. 2010;142(2):260–5.
Semaan MT, Alagramam KN, Megerian CA. The basic science of Meniere’s disease and endolymphatic hydrops. Curr Opin Otolaryngol Head Neck Surg. 2005;13(5):301–7.
Megerian CA, Semaan MT, Aftab S, Kisley LB, Zheng QY, Pawlowski KS, et al. A mouse model with postnatal endolymphatic hydrops and hearing loss. Hear Res. 2008;237(1–2):90–105.
Semaan MT, Zheng QY, Han F, Zheng Y, Yu H, Heaphy JC, et al. Characterization of neuronal cell death in the spiral ganglia of a mouse model of endolymphatic hydrops. Otol Neurotol. 2013;34(3):559–69.
Wick CC, Semaan MT, Zheng QY, Megerian CA. A genetic murine model of endolymphatic hydrops: the phex mouse. Curr Otorhinolaryngol Rep. 2014;2(3):144–51.
Sepahdari AR, Vorasubin N, Ishiyama G, Ishiyama A. Endolymphatic hydrops reversal following acetazolamide therapy: demonstration with delayed intravenous contrast-enhanced 3D-FLAIR MRI. AJNR Am J Neuroradiol. 2016;37(1):151–4.
Ikeda K, Kusakari J, Takasaka T, Saito Y. Early effects of acetazolamide on anionic activities of the guinea pig endolymph: evidence for active function of carbonic anhydrase in the cochlea. Hear Res. 1987;31(3):211–6.
Klockhoff I, Lindblom U. Glycerol test in Meniere’s disease. Acta Otolaryngol. 1966;Suppl 224:449+.
Shinkawa H, Kimura RS. Effect of diuretics on endolymphatic hydrops. Acta Otolaryngol. 1986;101(1–2):43–52.
Crowson MG, Patki A, Tucci DL. A systematic review of diuretics in the medical management of Meniere’s disease. Otolaryngol Head Neck Surg. 2016;154(5):824–34.
Morrison AW, Bailey ME, Morrison GA. Familial Meniere’s disease: clinical and genetic aspects. J Laryngol Otol. 2009;123(1):29–37.
Birgerson L, Gustavson KH, Stahle J. Familial Meniere’s disease: a genetic investigation. Am J Otol. 1987;8(4):323–6.
Arweiler-Harbeck D, Horsthemke B, Jahnke K, Hennies HC. Genetic aspects of familial Meniere’s disease. Otol Neurotol. 2011;32(4):695–700.
Ohmen JD, White CH, Li X, Wang J, Fisher LM, Zhang H, et al. Genetic evidence for an ethnic diversity in the susceptibility to Meniere’s disease. Otol Neurotol. 2013;34(7):1336–41.
Hietikko E, Kotimaki J, Okuloff A, Sorri M, Mannikko M. A replication study on proposed candidate genes in Meniere’s disease, and a review of the current status of genetic studies. Int J Audiol. 2012;51(11):841–5.
Campbell CA, Della Santina CC, Meyer NC, Smith NB, Myrie OA, Stone EM, et al. Polymorphisms in KCNE1 or KCNE3 are not associated with Meniere disease in the Caucasian population. Am J Med Genet A. 2010;152A(1):67–74.
Doi K, Sato T, Kuramasu T, Hibino H, Kitahara T, Horii A, et al. Meniere’s disease is associated with single nucleotide polymorphisms in the human potassium channel genes, KCNE1 and KCNE3. ORL J Otorhinolaryngol Relat Spec. 2005;67(5):289–93.
Fransen E, Verstreken M, Verhagen WI, Wuyts FL, Huygen PL, D’Haese P, et al. High prevalence of symptoms of Meniere’s disease in three families with a mutation in the COCH gene. Hum Mol Genet. 1999;8(8):1425–9.
Sanchez E, Lopez-Escamez JA, Lopez-Nevot MA, Lopez-Nevot A, Cortes R, Martin J. Absence of COCH mutations in patients with Meniere disease. Eur J Hum Genet. 2004;12(1):75–8.
Requena T, Cabrera S, Martin-Sierra C, Price SD, Lysakowski A, Lopez-Escamez JA. Identification of two novel mutations in FAM136A and DTNA genes in autosomal-dominant familial Meniere’s disease. Hum Mol Genet. 2015;24(4):1119–26.
Bernstein JM, Shanahan TC, Schaffer FM. Further observations on the role of the MHC genes and certain hearing disorders. Acta Otolaryngol. 1996;116(5):666–71.
Chiarella G, Petrolo C, Cassandro E. The genetics of Meniere’s disease. Appl Clin Genet. 2015;8:9–17.
Mhatre AN, Jero J, Chiappini I, Bolasco G, Barbara M, Lalwani AK. Aquaporin-2 expression in the mammalian cochlea and investigation of its role in Meniere’s disease. Hear Res. 2002;170(1–2):59–69.
Vrabec JT. Genetic investigations of Meniere’s disease. Otolaryngol Clin N Am. 2010;43(5):1121–32.
Candreia C, Schmuziger N, Gurtler N. Molecular analysis of aquaporin genes 1 to 4 in patients with Meniere’s disease. Cell Physiol Biochem. 2010;26(4–5):787–92.
Aoki M, Ando K, Kuze B, Mizuta K, Hayashi T, Ito Y. The association of antidiuretic hormone levels with an attack of Meniere’s disease. Clin Otolaryngol. 2005;30(6):521–5.
Aoki M, Asai M, Nishihori T, Mizuta K, Ito Y, Ando K. The relevance of an elevation in the plasma vasopressin levels to the pathogenesis of Meniere’s attack. J Neuroendocrinol. 2007;19(11):901–6.
Maekawa C, Kitahara T, Kizawa K, Okazaki S, Kamakura T, Horii A, et al. Expression and translocation of aquaporin-2 in the endolymphatic sac in patients with Meniere’s disease. J Neuroendocrinol. 2010;22(11):1157–64.
Kitahara T, Okamoto H, Fukushima M, Sakagami M, Ito T, Yamashita A, et al. A two-year randomized trial of interventions to decrease stress hormone vasopressin production in patients with Meniere’s disease-a pilot study. PLoS One. 2016;11(6):e0158309.
Takeda T, Takeda S, Kitano H, Okada T, Kakigi A. Endolymphatic hydrops induced by chronic administration of vasopressin. Hear Res. 2000;140(1–2):1–6.
Gates P. Hypothesis: could Meniere’s disease be a channelopathy? Intern Med J. 2005;35(8):488–9.
Wangemann P. K+ cycling and the endocochlear potential. Hear Res. 2002;165(1–2):1–9.
Yazawa Y, Suzuki M, Hanamitsu M, Kimura H, Tooyama I. Detection of viral DNA in the endolymphatic sac in Meniere’s disease by in situ hybridization. ORL J Otorhinolaryngol Relat Spec. 2003;65(3):162–8.
Vrabec JT. Herpes simplex virus and Meniere’s disease. Laryngoscope. 2003;113(9):1431–8.
Gartner M, Bossart W, Linder T. Herpes virus and Meniere’s disease. ORL J Otorhinolaryngol Relat Spec. 2008;70(1):28–31. discussion
Pulec JL. Indications for surgery in Meniere’s disease. Laryngoscope. 1977;87(4 Pt 1):542–56.
Pulec JL. Meniere’s disease of syphilitic etiology. Ear Nose Throat J. 1997;76(8):508–10, 12 14, passim.
Miller ME, Makary C, Lopez IA, Ishiyama A. Endolymphatic hydrops in otologic syphilis: a temporal bone study. Otol Neurotol. 2010;31(4):681–6.
Paparella MM, de Sousa LC, Mancini F. Meniere’s syndrome and otitis media. Laryngoscope. 1983;93(11 Pt 1):1408–15.
Lin YS, Lin LC, Lee FP, Lee KJ. The prevalence of chronic otitis media and its complication rates in teenagers and adult patients. Otolaryngol Head Neck Surg. 2009;140(2):165–70.
Dornhoffer JL, Arenberg IK. Immune mechanisms in Meniere’s syndrome. Otolaryngol Clin N Am. 1997;30(6):1017–26.
Bovo R, Ciorba A, Martini A. Vertigo and autoimmunity. Eur Arch Otorhinolaryngol. 2010;267(1):13–9.
Hughes GB, Kinney SE, Barna BP, Calabrese LH. Autoimmune reactivity in Meniere’s disease: a preliminary report. Laryngoscope. 1983;93(4):410–7.
Gazquez I, Soto-Varela A, Aran I, Santos S, Batuecas A, Trinidad G, et al. High prevalence of systemic autoimmune diseases in patients with Meniere’s disease. PLoS One. 2011;6(10):e26759.
Derebery MJ, Berliner KI. Prevalence of allergy in Meniere’s disease. Otolaryngol Head Neck Surg. 2000;123(1 Pt 1):69–75.
Derebery MJ, Berliner KI. Allergy and its relation to Meniere’s disease. Otolaryngol Clin N Am. 2010;43(5):1047–58.
Derebery MJ. Allergic management of Meniere’s disease: an outcome study. Otolaryngol Head Neck Surg. 2000;122(2):174–82.
Wackym PA, Friberg U, Linthicum FH Jr, Bagger-Sjoback D, Bui HT, Hofman F, et al. Human endolymphatic sac: morphologic evidence of immunologic function. Ann Otol Rhinol Laryngol. 1987;96(3 Pt 1):276–81.
Adams JC. Clinical implications of inflammatory cytokines in the cochlea: a technical note. Otol Neurotol. 2002;23(3):316–22.
Yoo TJ, Shea J Jr, Ge X, Kwon SS, Yazawa Y, Sener O, et al. Presence of autoantibodies in the sera of Meniere’s disease. Ann Otol Rhinol Laryngol. 2001;110(5 Pt 1):425–9.
Brookes GB. Circulating immune complexes in Meniere’s disease. Arch Otolaryngol Head Neck Surg. 1986;112(5):536–40.
Kim SH, Kim JY, Lee HJ, Gi M, Kim BG, Choi JY. Autoimmunity as a candidate for the etiopathogenesis of Meniere’s disease: detection of autoimmune reactions and diagnostic biomarker candidate. PLoS One. 2014;9(10):e111039.
Gottschlich S, Billings PB, Keithley EM, Weisman MH, Harris JP. Assessment of serum antibodies in patients with rapidly progressive sensorineural hearing loss and Meniere’s disease. Laryngoscope. 1995;105(12 Pt 1):1347–52.
Yoo TJ, Yazawa Y, Tomoda K, Floyd R. Type II collagen-induced autoimmune endolymphatic hydrops in guinea pig. Science. 1983;222(4619):65–7.
Yoo TJ, Stuart JM, Kang AH, Townes AS, Tomoda K, Dixit S. Type II collagen autoimmunity in otosclerosis and Meniere’s disease. Science. 1982;217(4565):1153–5.
Mouadeb DA, Ruckenstein MJ. Antiphospholipid inner ear syndrome. Laryngoscope. 2005;115(5):879–83.
Kangasniemi E, Hietikko E. The theory of autoimmunity in Meniere’s disease is lacking evidence. Auris Nasus Larynx. 2017;45:399–406.
Murofushi T, Ozeki H, Inoue A, Sakata A. Does migraine-associated vertigo share a common pathophysiology with Meniere’s disease? Study with vestibular-evoked myogenic potential. Cephalalgia. 2009;29(12):1259–66.
Ibekwe TS, Fasunla JA, Ibekwe PU, Obasikene GC, Onakoya PA, Nwaorgu OG. Migraine and Meniere’s disease: two different phenomena with frequently observed concomitant occurrences. J Natl Med Assoc. 2008;100(3):334–8.
Rassekh CH, Harker LA. The prevalence of migraine in Meniere’s disease. Laryngoscope. 1992;102(2):135–8.
Gurkov R, Kantner C, Strupp M, Flatz W, Krause E, Ertl-Wagner B. Endolymphatic hydrops in patients with vestibular migraine and auditory symptoms. Eur Arch Otorhinolaryngol. 2014;271(10):2661–7.
Cha YH, Kane MJ, Baloh RW. Familial clustering of migraine, episodic vertigo, and Meniere’s disease. Otol Neurotol. 2008;29(1):93–6.
Foster CA, Breeze RE. The Meniere attack: an ischemia/reperfusion disorder of inner ear sensory tissues. Med Hypotheses. 2013;81(6):1108–15.
Mom T, Chazal J, Gabrillargues J, Gilain L, Avan P. Cochlear blood supply: an update on anatomy and function. Fr Orl. 2005;88:81–8.
Balatsouras DG, Ganelis P, Aspris A, Economou NC, Moukos A, Koukoutsis G. Benign paroxysmal positional vertigo associated with Meniere’s disease: epidemiological, pathophysiologic, clinical, and therapeutic aspects. Ann Otol Rhinol Laryngol. 2012;121(10):682–8.
Gross EM, Ress BD, Viirre ES, Nelson JR, Harris JP. Intractable benign paroxysmal positional vertigo in patients with Meniere’s disease. Laryngoscope. 2000;110(4):655–9.
Jahn AF. Benign positional vertigo and endolymphatic hydrops: what is the connection? J Laryngol Otol. 2017;131(8):658–60.
Yamane H, Sunami K, Iguchi H, Sakamoto H, Imoto T, Rask-Andersen H. Assessment of Meniere’s disease from a radiological aspect – saccular otoconia as a cause of Meniere’s disease? Acta Otolaryngol. 2012;132(10):1054–60.
Morita N, Cureoglu S, Nomiya S, Nomiya R, Joglekar SS, Harada T, et al. Potential cause of positional vertigo in Meniere’s disease. Otol Neurotol. 2009;30(7):956–60.
Thomsen J, Sass K, Odkvist L, Arlinger S. Local overpressure treatment reduces vestibular symptoms in patients with Meniere’s disease: a clinical, randomized, multicenter, double-blind, placebo-controlled study. Otol Neurotol. 2005;26(1):68–73.
Mirza S, Gokhale S. Pathophysiology of Meniere’s disease. In: Up to date on Meniere’s disease. Rijeka: InTech; 2017.
Ferster APO, Cureoglu S, Keskin N, Paparella MM, Isildak H. Secondary endolymphatic hydrops. Otol Neurotol. 2017;38(5):774–9.
Schuknecht H. Correlation of pathology with symptoms of Meniere’s disease. Otolaryngol Clin N Am. 1968;1:433–40.
Valk WL, Wit HP, Albers FW. Rupture of Reissner’s membrane during acute endolymphatic hydrops in the guinea pig: a model for Meniere’s disease? Acta Otolaryngol. 2006;126(10):1030–5.
Brown DH, McClure JA, Downar-Zapolski Z. The membrane rupture theory of Meniere’s disease – is it valid? Laryngoscope. 1988;98(6 Pt 1):599–601.
Gibson WP. Hypothetical mechanism for vertigo in Meniere’s disease. Otolaryngol Clin N Am. 2010;43(5):1019–27.
Brandt T. Vertigo: its multisensory syndromes. New York: Springer Science & Business Media; 2013.
Ozeki H, Iwasaki S, Murofushi T. Vestibular drop attack secondary to Meniere’s disease results from unstable otolithic function. Acta Otolaryngol. 2008;128(8):887–91.
Urushitani M, Nakamizo T, Inoue R, Sawada H, Kihara T, Honda K, et al. N-methyl-D-aspartate receptor-mediated mitochondrial Ca(2+) overload in acute excitotoxic motor neuron death: a mechanism distinct from chronic neurotoxicity after Ca(2+) influx. J Neurosci Res. 2001;63(5):377–87.
Michel O, Hess A, Su J, Bloch W, Stennert E, Addicks K. Expression of inducible nitric oxide synthase (iNOS/NOS II) in the hydropic cochlea of guinea pigs. Hear Res. 2000;143(1–2):23–8.
Watanabe K, Tomiyama S, Jinnouchi K, Hess A, Michel O, Yagi T. Expression of inducible nitric oxide synthase (iNOS/NOS II) in the hydropic vestibule after injection of keyhole limpet hemocyanin into the endolymphatic sac of guinea pigs. J Vestib Res. 2001;11(2):67–71.
Kim H, Wiet R, Battista R. Trends in the diagnosis and the management of meniere’s disease: results of a survey. Otolaryngol Head Neck Surg. 2005;132:722–6.
Bance M, Mai M, Tomlinson D, Rutka J. The changing direction of nystagmus in acute Menière’s disease: pathophysiological implications. Laryngoscope. 1991;101:197–201.
Brown DH, McClure JA, Downar-Zapolski Z. The membrane rupture theory of Menière’s disease – is it valid? Laryngoscope. 1988;98:599–601.
Hirai C, Yamamoto Y, Takeda T, Tasaki A, Inaba Y, Kiyokawa Y, et al. Nystagmus at the onset of vertiginous attack in Ménièreʼs disease. Otol Neurotol. 2017;38:110–3.
Kuo S-W, Yang T-H, Young Y-H. Changes in vestibular evoked myogenic potentials after Meniere attacks. Ann Otol Rhinol Laryngol. 2005;114:717–21.
McClure JA, Copp JC, Lycett P. Recovery nystagmus in Ménière’s disease. Laryngoscope. 1981;91:1727–37.
Aschan G, Stahle J. Nystagmus in Menière’s disease during attacks; a nystagmographical study. Acta Otolaryngol (Stockh). 1957;47:189–201.
Nishikawa K, Nishikawa M. Nystagmus during attack in Menière’s disease. Auris Nasus Larynx. 1986;13(Suppl 2):S147–51.
Kim C-H, Shin JE, Kim TS, Shim BS, Park HJ. Two-dimensional analysis of head-shaking nystagmus in patients with Meniere’s disease. J Vestib Res. 2013;23:95–100.
Lee S-U, Kee H-J, Sheen SS, Choi BY, Koo J-W, Kim K-S. Head-shaking and vibration-induced nystagmus during and between the attacks of unilateral Ménière’s disease. Otol Neurotol. 2015;36(5):865–72.
Lee S-U, Kim H-J, Koo J-W, Kim J-S. Comparison of caloric and head-impulse tests during the attacks of Meniere’s disease. Laryngoscope. 2017;127:702–8.
Park HJ, Migliaccio AA, Della Santina CC, Minor LB, Carey JP. Search-coil head-thrust and caloric tests in Ménière’s disease. Acta Otolaryngol (Stockh). 2005;125:852–7.
Zhang Y, Liu B, Wang R, Jia R, Gu X. Characteristics of the cochlear symptoms and functions in Meniere’s disease. Chin Med J. 2016;129:2445–50.
Paparella MM, McDermott JC, de Sousa LC. Meniere’s disease and the peak audiogram. Arch Otolaryngol. 1982;108:555–9.
Lee CS, Paparella MM, Margolis RH, Le C. Audiological profiles and Menière’s disease. Ear Nose Throat J. 1995;74:527–32.
Mammarella F, Zelli M, Varakliotis T, Eibenstein A, Pianura CM, Bellocchi G. Is electrocochleography still helpful in early diagnosis of Meniere disease? J Audiol Otol. 2017;21:72–6.
Hornibrook J. Tone burst electrocochleography for the diagnosis of clinically certain Meniere’s disease. Front Neurosci. 2017;11:301.
Sass K. Sensitivity and specificity of transtympanic electrocochleography in Meniere’s disease. Acta Otolaryngol. 1998;118:150–6.
Gibson WP. The use of electrocochleography in the diagnosis of Meniére’s disease. Acta Otolaryngol Suppl. 1991;485:46–52.
Conlon BJ, Gibson WP. Electrocochleography in the diagnosis of Meniere’s disease. Acta Otolaryngol. 2000;120:480–3.
Kim HH, Kumar A, Battista RA, Wiet RJ. Electrocochleography in patients with Meniere’s disease. Am J Otolaryngol. 2005;26:128–31.
McGarvie LA, Curthoys IS, MacDougall HG, Halmagyi GM. What does the dissociation between the results of video head impulse versus caloric testing reveal about the vestibular dysfunction in Ménière’s disease? Acta Otolaryngol (Stockh). 2015;135:859–65.
Blödow A, Heinze M, Bloching MB, von Brevern M, Radtke A, Lempert T. Caloric stimulation and video-head impulse testing in Ménière’s disease and vestibular migraine. Acta Otolaryngol (Stockh). 2014;134:1239–44.
Yacovino DA, Hain TC, Musazzi M. Fluctuating Vestibulo-ocular reflex in Ménièreʼs disease. Otol Neurotol. 2017;38:244–7.
Katayama N, Yamamoto M, Teranishi M, Naganawa S, Nakata S, Sone M, et al. Relationship between endolymphatic hydrops and vestibular-evoked myogenic potential. Acta Otolaryngol. 2010;130:917–23.
Young Y-H, Huang T-W, Cheng P-W. Assessing the stage of Ménière’s disease using vestibular evoked myogenic potentials. Arch Otolaryngol Head Neck Surg. 2003;129:815.
Kubo T, Sakashita T, Kusuki M, Nakai Y. Frequency analysis of evoked otoacoustic emissions in Meniére’s disease. Acta Otolaryngol Suppl. 1995;519:275–81.
Harris FP, Probst R. Transiently evoked otoacoustic emissions in patients with Menière’s disease. Acta Otolaryngol (Stockh). 1992;112:36–44.
Drexl M, Krause E, Gürkov R. A comparison of distortion product otoacoustic emission properties in Ménière’s disease patients and normal-hearing participants. Ear Hear. 2017;39(1):42–7.
Avan P, Giraudet F, Chauveau B, Gilain L, Mom T. Unstable distortion-product otoacoustic emission phase in MeniEre’s disease. Hear Res. 2011;277(1–2):88–95.
Nakashima T, Naganawa S, Sugiura M, Teranishi M, Sone M, Hayashi H, et al. Visualization of endolymphatic hydrops in patients with Meniere’s disease. Laryngoscope. 2007;117:415–20.
Naganawa S, Suzuki K, Nakamichi R, Bokura K, Yoshida T, Sone M, et al. Semi-quantification of endolymphatic size on MR imaging after intravenous injection of single-dose gadodiamide: comparison between two types of processing strategies. Magn Reson Med Sci. 2013;12:261–9.
Yoshida T, Sugimoto S, Teranishi M, Otake H, Yamazaki M, Naganawa S, et al. Imaging of the endolymphatic space in patients with Ménière’s disease. Auris Nasus Larynx. 2017;S0385-8146(17):30142–6.
Baráth K, Schuknecht B, Naldi AM, Schrepfer T, Bockisch CJ, Hegemann SCA. Detection and grading of endolymphatic hydrops in Menière disease using MR imaging. AJNR Am J Neuroradiol. 2014;35:1387–92.
Taguchi D, Kakigi A, Takeda T, Sawada S, Nakatani H. Diagnostic value of plasma antidiuretic hormone, electrocochleography, and glycerol test in patients with endolymphatic hydrops. ORL J Otorhinolaryngol Relat Spec. 2010;71(Suppl 1):26–9.
Kakigi A, Takeda T. Antidiuretic hormone and osmolality in patients with Meniere’s disease. ORL J Otorhinolaryngol Relat Spec. 2009;71:11–3.
Takeda T, Kakigi A, Saito H. Antidiuretic hormone (ADH) and endolymphatic hydrops. Acta Otolaryngol Suppl. 1995;519:219–22.
Klockhoff I, Lindblom U. Endolymphatic hydrops revealed by glycerol test. Preliminary report. Acta Otolaryngol (Stockh). 1966;61:459–62.
Dieterich M, Obermann M, Celebisoy N. Vestibular migraine: the most frequent entity of episodic vertigo. J Neurol. 2016;263(Suppl 1):S82–9.
Neff BA, Staab JP, Eggers SD, Carlson ML, Schmitt WR, Van Abel KM, et al. Auditory and vestibular symptoms and chronic subjective dizziness in patients with Ménière’s disease, vestibular migraine, and Ménière’s disease with concomitant vestibular migraine. Otol Neurotol. 2012;33:1235–44.
Gürkov R, Kantner C, Strupp M, Flatz W, Krause E, Ertl-Wagner B. Endolymphatic hydrops in patients with vestibular migraine and auditory symptoms. Eur Arch Otorhinolaryngol. 2014;271:2661–7.
Taylor RL, Zagami AS, Gibson WP, Black DA, Watson SR, Halmagyi MG, et al. Vestibular evoked myogenic potentials to sound and vibration: characteristics in vestibular migraine that enable separation from Meniere’s disease. Cephalalgia. 2012;32:213–25.
Inoue A, Egami N, Fujimoto C, Kinoshita M, Yamasoba T, Iwasaki S. Vestibular evoked myogenic potentials in vestibular migraine. Ann Otol Rhinol Laryngol. 2016;125:931–7.
Zuniga MG, Janky KL, Schubert MC, Carey JP. Can vestibular-evoked myogenic potentials help differentiate Ménière disease from vestibular migraine? Otolaryngol Head Neck Surg. 2012;146:788–96.
Sharon JD, Hullar TE. Motion sensitivity and caloric responsiveness in vestibular migraine and Meniere’s disease. Laryngoscope. 2014;124:969–73.
Soto E, Vega R. Neuropharmacology of vestibular system disorders. Curr Neuropharmacol. 2010;8:26–40.
Ghavami Y, Mahboubi H, Yau AY, Maducdoc M, Djalilian HR. Migraine features in patients with Meniere’s disease. Laryngoscope. 2016;126:163–8.
Nomura Y. Morphological aspects of inner ear disease. Tokyo: Springer Science & Business Media; 2013.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Luryi, A.L., Morse, E., Michaelides, E. (2019). Pathophysiology and Diagnosis of Meniere’s Disease. In: Babu, S., Schutt, C., Bojrab, D. (eds) Diagnosis and Treatment of Vestibular Disorders. Springer, Cham. https://doi.org/10.1007/978-3-319-97858-1_13
Download citation
DOI: https://doi.org/10.1007/978-3-319-97858-1_13
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-97857-4
Online ISBN: 978-3-319-97858-1
eBook Packages: MedicineMedicine (R0)